Urvi Shah
@UrviShahMD
Followers
4K
Following
10K
Media
286
Statuses
4K
Oncologist and researcher on Myeloma service @mskcancercenter Interested in nutrition đ± for cancer and immune therapies. Cancer survivor. Views are my own
New York, NY
Joined September 2017
Thank you @MSKCancerCenter for featuring our nutrition research in MSK News summer edition! And also interviewing Will Wright about his experience on the NUTRIVENTION trial too @MSK_DeptOfMed
#mmsm #nutrition #cancer #lymsm #leuksm
https://t.co/ERc5m43XwL
mskcc.org
When Dr. Urvi Shah was diagnosed with Hodgkin lymphoma in 2016 during her first year as a hematology-oncology fellow, she heard lots of recommendations from friends and family about what she should...
3
32
166
Today is #NationalFoodDay, which promotes eating healthy and swapping sugary drinks and meat for vegetables, fruits, and whole grains. Studies by @UrviShahMD and colleagues show that plant-based diets are linked with reduced risk of MGUS and #myeloma. âĄïž https://t.co/DMJoQt6LQJ
0
1
1
Conflict of research interest: I prescribe #sirolimus and also feel myself rapidly #aging đ đ€, so naturally I've always wondered if sirolimus helped slow the clock when used in allogeneic HCT. Hats off to Drs. Najla El Jurdi @NIH and @MattYousefzadeh @Columbia for digging
frontiersin.org
Allogeneic hematopoietic cell transplantation (HCT) is often the only curative therapy for hematologic malignancies. Immune suppression is necessary for the ...
1
6
20
Exercise is a key step for lower cancer risk. Studies estimate that three percent of all U.S. cancer cases annually (approx 46,000 cases) could be prevented if inactive adults were to meet the physical activity guidelines of five hours per week. Learn more https://t.co/ri1oQtvebL
0
3
4
Fantastic event w discussion, debates, & exchange of knowledge, ideas, and opinions at the Kyle Barlogie #PlasmaCellDisorders symposium #MMSM @MSK_DeptOfMed @MayoClinic #MedTwitter #MedEd
@szusmani @VincentRK @myelomaMD @FrancescoMaura4 @UrviShahMD @sridevirajeeve & many others
0
5
23
1/ Thanks Larry (and all co-authors) and @AjHematology for this! RW data for a frequent q in my own #MMsm clinic, namely patients starting teclistamab disappointed by D30 results after hearing "Median time to 1st response 1.1 mo"... Can we predict delayed response conversion?
Great job leading this one @RahulBanerjeeMD D30 ALC is a significant predictor of delayed responses to Tec in RRMM for initial non-responders. American Journal of Hematology | https://t.co/RT7oxhYR07
@GKaurMD @AlGarfall @SurbhiSidanaMD @utswcancer
3
13
50
Excited to share new study out today on @JCO_ASCO where we leveraged #WGS to reclassify MGUS and SMM and define the concept of "malignant transformation" @MSKCancerCenter @LaStatale @MDAndersonNews @MoffittNews @SylvesterCancer @nyulangone @sangerinstitute @MayoClinic #mmsm 1/14
8
37
88
#lifestylemedicine in practice! @ACLifeMed
1
2
6
Thrilled to present our research on diet and biliary tract cancer this afternoon at #ACSCC2025! Stop by HPB III session if you are interested in our findings.
3
3
24
Our immune system is an evolutionary masterpiece. Every day it protects us from the thousands of different viruses, bacteria and other microbes that attempt to invade our bodies. Without a functioning immune system, we would not survive. One of the immune systemâs marvels is its
92
3K
8K
BREAKING NEWS The 2025 #NobelPrize in Physiology or Medicine has been awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi âfor their discoveries concerning peripheral immune tolerance.â
469
12K
29K
The @NobelPrize in Physiology or Medicine will be announced tomorrow morning at 5:30am EST. I have always enjoyed following the âSheltzer Derbyâ. In the past couple of years, the prize has gone to those in the â5â category amongst predictor prizes. Letâs see if that holds in 2025
In two weeks, the 2025 Nobel Prizes will be announced. Based on looking at other pre-Nobel âpredictorâ prizes, I think that these 36 scientists are the most likely candidates:
4
2
25
Our comment @NatRevGastroHep summarizes the evidence and ongoing trials investigating diet in GI cancer survival, including potential underlying mechanisms and future research directions. @FionaMalcomson @MihirMShah1 @MSK_DeptOfMed @MSKCancerCenter
https://t.co/HPIYWKp1tG
1
5
19
Does this resonate with you? âŠ@jmikhaelmdâ© says âI donât treat #myeloma, I treat peopleâ âŠ@IMFmyelomaâ© âŠ@IMFmikeMYELOMAâ© âŠ@JWieworkâ©
3
3
16
The next time your paper is rejected by a medical journal for reasons that baffle youâŠ
En 1981 The New Yorker rechazĂł la publicaciĂłn de un relato de Gabriel GarcĂa MĂĄrquez, "El rastro de tu sangre en la nieve", que serĂa posteriormente editado junto con otros cuentos en el volumen "Doce cuentos peregrinos". Un año despuĂ©s, GarcĂa MĂĄrquez obtuvo el premio Nobel.
5
23
160
Monoclonal gammopathy of undetermined significance is a common, asymptomatic plasma-cell disorder in older adults that can progress to cancer or systemic illness. Diagnosis warrants follow-up, but treatment is not required unless progression is confirmed. Learn more in the
3
22
117
Iâll be speaking at this meeting next week. Also speaking are @szusmani @FrancescoMaura4 @UrviShahMD @sridevirajeeve @LesokhinMD and more from @MSKCancerCenter And many of my colleagues from @MayoClinic including @MorieGertz @ADispenzieri @myelomaMD @JoselleCookMD
2
10
49
*Press Release* The International Myeloma Foundation announced Heather Cooper Ortner â President & CEO of Alzheimerâs Los Angeles, & former CEO of the Dr. Susan Love Research Foundation â has been named as the IMFâs new President & Chief Executive Officer. https://t.co/mn0tsmrAK9
1
6
15